Minerva Neurosciences Inc (NERV)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Rémy Luthringer
Employees:
13
1601 TRAPELO ROAD, SUITE 286, WALTHAM, MA 02451
617-600-7373

Minerva Neurosciences, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. The company's product portfolio includes MIN-101, MIN-117, MIN-202 and MIN-301. Minerva Neurosciences was founded by Rogerio Vivaldi Coelho on April 23, 2007 and is headquartered in Cambridge, MA.

Data derived from most recent annual or quarterly report
Market Cap 135.427 Million Shares Outstanding42.722 Million Avg 30-day Volume 284.086 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.46
Price to Revenue0.0 Debt to Equity0.0 EBITDA-45.788 Million
Price to Book Value0.0 Operating Margin0.0 Enterprise Value-19.579 Million
Current Ratio17.15 EPS Growth-8.933 Quick Ratio16.919
1 Yr BETA 4.843 52-week High/Low 3.63 / 0.33 Profit Margin0.0
Operating Cash Flow Growth15.5649 Altman Z-Score-7.782 Free Cash Flow to Firm -11.176 Million
Earnings Report2022-08-03
View SEC Filings from NERV instead.

View recent insider trading info

Minerva Neurosciences Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding NERV (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NERV BETA

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2022-02-18 by AHLHOLM FREDERICK W
  • 4: filed on 2022-02-18 by Race Geoff
  • 4: filed on 2022-02-18 by LUTHRINGER REMY
  • 4: filed on 2021-12-03 by KUPFER DAVID
  • 4: filed on 2021-06-16 by HASLER HANS PETER
  • 4: filed on 2021-06-15 by DOYLE WILLIAM F
  • 4: filed on 2021-06-15 by VAN HEEK G JAN
  • 4: filed on 2021-06-15 by HILLEMAN JERYL L
  • 4: filed on 2021-06-15 by LAGHRISSI-THODE FOUZIA
  • 4: filed on 2021-06-15 by KUPFER DAVID

    • Events (8k)

  • 8-K: filed on 2022-06-17:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-15:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-04-13:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-07:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-14:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2022-02-28:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-18:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2022-01-05:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-12-08:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-03:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    AHLHOLM FREDERICK W CFO

    • Officer
    		 180,000 2022-02-16 1

    RACE GEOFF PRESIDENT

    • Officer
    		 200,000 2022-02-16 1

    LUTHRINGER REMY CEO

    • Officer
    • Director
    		 505,000 2022-02-16 1

    KUPFER DAVID

    • Director
    		 191,488 2021-12-01 1

    VAN HEEK G JAN

    • Director
    		 20,000 2021-06-11 0

    DOYLE WILLIAM F

    • Director
    		 40,000 2021-06-11 0

    HILLEMAN JERYL L

    • Director
    		 20,000 2021-06-11 0

    HASLER HANS PETER

    • Director
    		 20,000 2021-06-11 0

    LAGHRISSI-THODE FOUZIA

    • Director
    		 20,000 2021-06-11 0

    REILLY JOSEPH H. SVP & CHIEF OPERATING OFFICER

    • Officer
    		 31,747 2020-12-14 0

    DAVIDSON MICHAEL CHIEF MEDICAL OFFICER

    • Officer
    		 0 2020-10-13 0

    SAOUD JAY SVP AND HEAD OF R&D

    • Officer
    		 0 2020-10-13 0

    SMITH DEVIN WHITTEMORE SVP AND GENERAL COUNSEL

    • Officer
    		 0 2020-10-13 0

    RUSSELL RICHARD E. PRESIDENT

    • Officer
    		 0 2020-06-19 0

    INDEX VENTURE ASSOCIATES III LTD

    INDEX VENTURE ASSOCIATES IV LTD

    INDEX VENTURE ASSOCIATES V LTD

    YUCCA (JERSEY) SLP

    • 10% Owner
    		 No longer subject to file 2019-06-24 0

    BEER MARC D

    • Director
    		 0 2018-01-31 0

    JOHNSON & JOHNSON

    JOHNSON & JOHNSON INNOVATION - JJDC, INC.

    • 10% Owner
    		 No longer subject to file 2017-08-29 0

    VANDERVELPEN NICO

    • Director
    		 No longer subject to file 2017-07-24 0

    LEVINE MARK S. SVP,GENERAL COUNSEL & SEC.

    • Officer
    		 0 2017-06-01 0

    OLLIER MICHELE

    • Director
    • 10% Owner
    		 4,690,906 2016-12-12 0

    DE RUBERTIS FRANCESCO

    • Director
    • 10% Owner
    		 4,690,906 2016-12-12 0

    CARE CAPITAL III LLC

    CARE CAPITAL INVESTMENTS III L.P.

    CARE CAPITAL OFFSHORE INVESTMENTS III LP

    • 10% Owner
    		 No longer subject to file 2015-03-18 0

    PELLEGRINI LORENZO

    • Director
    • 10% Owner
    		 10,112,713 2014-07-07 0

    VIVALDI COELHO ROGERIO PRESIDENT AND CEO

    • Officer
    • Director
    		 0 2014-06-30 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    MINERVA NEUROSCIENCES INC NERV 2022-06-24 22:15:03 UTC 0.5243 1.0457 60000
    MINERVA NEUROSCIENCES INC NERV 2022-06-24 21:45:03 UTC 0.5243 1.0457 60000
    MINERVA NEUROSCIENCES INC NERV 2022-06-24 21:15:04 UTC 0.5243 1.0457 60000
    MINERVA NEUROSCIENCES INC NERV 2022-06-24 20:45:03 UTC 0.5243 1.0457 60000
    MINERVA NEUROSCIENCES INC NERV 2022-06-24 20:15:03 UTC 0.5243 1.0457 60000
    MINERVA NEUROSCIENCES INC NERV 2022-06-24 19:45:03 UTC 0.5243 1.0457 60000
    MINERVA NEUROSCIENCES INC NERV 2022-06-24 19:15:03 UTC 0.5243 1.0457 60000
    MINERVA NEUROSCIENCES INC NERV 2022-06-24 18:45:03 UTC 0.4657 1.1043 60000
    MINERVA NEUROSCIENCES INC NERV 2022-06-24 18:15:04 UTC 0.4657 1.1043 60000
    MINERVA NEUROSCIENCES INC NERV 2022-06-24 17:45:03 UTC 0.4657 1.1043 60000
    MINERVA NEUROSCIENCES INC NERV 2022-06-24 17:15:03 UTC 0.4657 1.1043 60000
    MINERVA NEUROSCIENCES INC NERV 2022-06-24 16:45:03 UTC 0.4953 1.0747 60000
    MINERVA NEUROSCIENCES INC NERV 2022-06-24 16:15:03 UTC 0.4953 1.0747 60000
    MINERVA NEUROSCIENCES INC NERV 2022-06-24 15:45:03 UTC 0.4953 1.0747 60000
    MINERVA NEUROSCIENCES INC NERV 2022-06-24 15:15:03 UTC 0.4953 1.0747 55000
    MINERVA NEUROSCIENCES INC NERV 2022-06-24 14:45:03 UTC 0.9144 0.6556 55000
    MINERVA NEUROSCIENCES INC NERV 2022-06-24 14:15:03 UTC 0.9144 0.6556 55000
    MINERVA NEUROSCIENCES INC NERV 2022-06-24 13:45:03 UTC 0.9144 0.6556 55000
    MINERVA NEUROSCIENCES INC NERV 2022-06-24 13:15:03 UTC 0.9144 0.6556 55000
    MINERVA NEUROSCIENCES INC NERV 2022-06-24 12:45:03 UTC 0.9144 0.6556 50000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund NERV -2800.0 shares, $-2324.56 2022-03-31 N-PORT

    Elevate your investments